Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL). [electronic resource]
Producer: 20160203Description: 504-10 p. digitalISSN:- 1600-0609
- Age Factors
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Consolidation Chemotherapy
- Cyclophosphamide -- adverse effects
- Doxorubicin -- adverse effects
- Drug Administration Schedule
- Female
- Humans
- Induction Chemotherapy
- Lymphoma, Large B-Cell, Diffuse -- diagnosis
- Male
- Neoplasm Staging
- Prednisone -- adverse effects
- Rituximab -- administration & dosage
- Treatment Outcome
- Vincristine -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.